Sigilon Therapeutics (SGTX) has filed to raise $101 million from the sale of its common stock in an IPO, according to an amended registration statement. Cambridge, Massachusetts-based Sigilon was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback